Nuvation Bio Insider Trades
NYSE: NUVBHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 1 · $118.25K
- Sales
- 10 · $4.80M
- Shares bought / sold
- 25.00K / 792.42K
- Net activity
- Net selling $4.7 million
Nuvation Bio insider activity
Over the last 12 months, Nuvation Bio insiders reported 26 transactions on SEC Form 4: 1 open-market purchase and 10 sales. Insiders bought $118,250 and sold $4.8 million worth of stock, for net insider selling of $4.7 million. The largest seller was Liu Dongfang, with $1.6 million in reported sales.
The most recent filing shows Hattersley Gary (CHIEF SCIENTIFIC OFFICER) reporting a transaction in 100,000 shares at $1.87 on Aug 19, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put NUVB's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
NUVB insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Aug 19, 2026 | Hattersley GaryCHIEF SCIENTIFIC OFFICER | Sale | 100,000 | $709.24K | Form 4 |
| Aug 19, 2026 | Hattersley GaryCHIEF SCIENTIFIC OFFICER | Option exercise | 100,000 | $187.00K | Form 4 |
| Jul 15, 2026 | Sauvage PhilippeChief Financial Officer | Option exercise | 1 | $1.97 | Form 4 |
| Jul 15, 2026 | Sauvage PhilippeChief Financial Officer | Option exercise | 39,999 | $86.80K | Form 4 |
| Jun 23, 2026 | Sauvage PhilippeChief Financial Officer | Sale | 47,668 | $286.37K | Form 4 |
| Jun 23, 2026 | Sauvage PhilippeChief Financial Officer | Option exercise | 47,668 | $103.44K | Form 4 |
| Jun 23, 2026 | Wentworth KerryCHIEF REGULATORY OFFICER | Sale | 63,000 | $379.19K | Form 4 |
| Jun 23, 2026 | Wentworth KerryCHIEF REGULATORY OFFICER | Option exercise | 63,000 | $184.59K | Form 4 |
| Jun 23, 2026 | Markel StacyCHIEF PEOPLE OFFICER | Sale | 125,000 | $753.19K | Form 4 |
| Jun 23, 2026 | Markel StacyCHIEF PEOPLE OFFICER | Option exercise | 34,620 | $60.24K | Form 4 |
| Jun 23, 2026 | Markel StacyCHIEF PEOPLE OFFICER | Option exercise | 90,380 | $169.01K | Form 4 |
| Jun 9, 2026 | Mashal RobertDirector | Buy | 25,000 | $118.25K | Form 4 |
| Apr 17, 2026 | Wentworth KerryCHIEF REGULATORY OFFICER | Sale | 36,750 | $184.28K | Form 4 |
| Apr 17, 2026 | Wentworth KerryCHIEF REGULATORY OFFICER | Option exercise | 36,750 | $107.68K | Form 4 |
| Apr 17, 2026 | Liu DongfangCHIEF MEDICAL OFFICER | Sale | 50,000 | $251.00K | Form 4 |
| Apr 17, 2026 | Liu DongfangCHIEF MEDICAL OFFICER | Option exercise | 50,000 | $97.00K | Form 4 |
| Apr 6, 2026 | Wentworth KerryCHIEF REGULATORY OFFICER | Sale | 200,000 | $903.56K | Form 4 |
| Apr 6, 2026 | Wentworth KerryCHIEF REGULATORY OFFICER | Option exercise | 100,000 | $194.00K | Form 4 |
| Apr 6, 2026 | Wentworth KerryCHIEF REGULATORY OFFICER | Option exercise | 100,000 | $187.00K | Form 4 |
| Feb 27, 2026 | Makunje MosesSEE REMARKS | Award | 50,761 | — | Form 4 |
| Dec 1, 2025 | Liu DongfangCHIEF MEDICAL OFFICER | Sale | 150,000 | $1.17M | Form 4 |
| Dec 1, 2025 | Liu DongfangCHIEF MEDICAL OFFICER | Option exercise | 150,000 | $439.50K | Form 4 |
| Nov 26, 2025 | Liu DongfangCHIEF MEDICAL OFFICER | Sale | 10,000 | $80.00K | Form 4 |
| Nov 26, 2025 | Liu DongfangCHIEF MEDICAL OFFICER | Option exercise | 10,000 | $36.10K | Form 4 |
| Nov 25, 2025 | Liu DongfangCHIEF MEDICAL OFFICER | Sale | 10,000 | $75.00K | Form 4 |
| Nov 25, 2025 | Liu DongfangCHIEF MEDICAL OFFICER | Option exercise | 10,000 | $36.10K | Form 4 |
| Nov 20, 2025 | Liu DongfangCHIEF MEDICAL OFFICER | Sale | 20,000 | $140.07K | Form 4 |
| Nov 20, 2025 | Liu DongfangCHIEF MEDICAL OFFICER | Option exercise | 20,000 | $37.40K | Form 4 |
| Nov 20, 2025 | Hattersley GaryCHIEF SCIENTIFIC OFFICER | Sale | 300,000 | $2.17M | Form 4 |
| Nov 20, 2025 | Hattersley GaryCHIEF SCIENTIFIC OFFICER | Option exercise | 300,000 | $582.00K | Form 4 |
| Nov 20, 2025 | Hattersley GaryCHIEF SCIENTIFIC OFFICER | Sale | 69,051 | $499.03K | Form 4 |
| Nov 20, 2025 | Hattersley GaryCHIEF SCIENTIFIC OFFICER | Option exercise | 69,051 | $120.15K | Form 4 |
| Nov 19, 2025 | Liu DongfangCHIEF MEDICAL OFFICER | Sale | 15,000 | $76.55K | Form 4 |
| Nov 19, 2025 | Liu DongfangCHIEF MEDICAL OFFICER | Option exercise | 15,000 | $28.05K | Form 4 |
| Nov 19, 2025 | Hanley David C.CHIEF TECHNICAL OPERATIONS | Sale | 200,000 | $1.43M | Form 4 |
| Nov 19, 2025 | Hanley David C.CHIEF TECHNICAL OPERATIONS | Option exercise | 200,000 | $374.00K | Form 4 |
| Nov 17, 2025 | Liu DongfangCHIEF MEDICAL OFFICER | Sale | 15,000 | $71.47K | Form 4 |
| Nov 17, 2025 | Liu DongfangCHIEF MEDICAL OFFICER | Option exercise | 15,000 | $28.05K | Form 4 |
| Oct 27, 2025 | Hattersley GaryCHIEF SCIENTIFIC OFFICER | Sale | 100,000 | $502.46K | Form 4 |
| Oct 27, 2025 | Hattersley GaryCHIEF SCIENTIFIC OFFICER | Option exercise | 100,000 | $174.00K | Form 4 |
| Jun 18, 2025 | Markel StacyCHIEF PEOPLE OFFICER | Buy | 10,000 | $17.10K | Form 4 |
| Jun 17, 2025 | Sauvage PhilippeChief Financial Officer | Buy | 4,000 | $7.16K | Form 4 |
| Jun 16, 2025 | Hung DavidPRESIDENT AND CEO | Buy | 500,000 | $893.50K | Form 4 |
| Jun 16, 2025 | Wentworth KerryCHIEF REGULATORY OFFICER | Buy | 24,000 | $43.20K | Form 4 |
| Jun 16, 2025 | Wentworth KerryCHIEF REGULATORY OFFICER | Buy | 26,000 | $46.54K | Form 4 |
| Jun 16, 2025 | Sjogren ColleenChief Commercial Officer | Buy | 50,000 | $90.35K | Form 4 |
| Jun 16, 2025 | Sauvage PhilippeChief Financial Officer | Buy | 3,300 | $6.06K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4